A number of problems still surround infection by the human immunodeficiency virus and the pathogenesis of AIDS. Solutions to the problems would provide valuable information for the development of antiviral therapy and a vaccine.
References
- 1
Fauci, A. S. Science 239, 617–622 (1988).
- 2
Maddon, P. J. et al. Cell 47, 333–348 (1986).
- 3
Cheng-Mayer, C. et al. Proc. natn. Acad. Sci. U.S.A. 84, 3526–3530 (1987).
- 4
Tateno, M. & Levy, J. A. IV Int. Conf. AIDS, Stockholm (abstr.), (1988).
- 5
Wiley, C. A. et al. Proc. natn. Acad. Sci. U.S.A. 88, 7089–7093 (1986).
- 6
Nelson, J. A. et al. Lancet i, 259–262 (1988).
- 7
Stein, B. S. et al. Cell 49, 659–668 (1987).
- 8
Gallaher, W. R. Cell 50, 327–328 (1987).
- 9
Chanh, T. C. et al. EMBO J. 5, 3065–3071 (1986).
- 10
Robinson, W. E. et al. Lancet i, 790–795 (1988).
- 11
Halstead, S. B. & O'Rourke, E. J. J. exp. Med. 146, 201–217 (1977).
- 12
Ho, D. D. et al. Science 239, 1021–1023 (1988).
- 13
Gartner, S. et al. Science 233, 215–219 (1986).
- 14
Levy, J. A. et al. Ann. Inst. Pasteur 138, 101–111 (1987).
- 15
Evans, L. A. et al. J. lmmun. 138, 3415–3418 (1987).
- 16
Levy J. A. et al. Science 232, 998–1001 (1986).
- 17
Nabel, G & Baltimore, D. Nature 326, 711–713 (1987).
- 18
Cheng-Mayer, C. et al. Science 240, 80–82 (1988).
- 19
Hahn, B. H. et al. Science 232, 1548–1553 (1986).
- 20
Starcich, B. R. et al. Cell 45, 637–648 (1986).
- 21
Weiss, R. A. et al. Nature 324, 572–575 (1986).
- 22
Evans, L. A. et al. Science 240, 1522–1525 (1988).
- 23
Luciw, P. A. et al. Nature 312, 760–763 (1984).
- 24
Robert-Guroff, M. et al. J. lmmun. 137, 3306–3309 (1986).
- 25
Carpenter, S. et al. J. Virol. 61, 3783–3789 (1987).
- 26
Price, R. W. et al. Science 239, 586–592 (1988).
- 27
Fontana, A. et al. Nature 307, 273–276 (1984).
- 28
Cohen, M. B. & Beckstead, J. in AIDS: Pathogenesis and Treatment (ed. Levy, J. A.) (Dekker, New York, in the press).
- 29
Harper, M. E. et al. Proc. natn. Acad. Sci. U.S.A. 83, 772–776 (1986).
- 30
Hoxie, J. A. et al. Science 229, 1400–1402 (1985).
- 31
Asjo, B et al. Lancet 2, 660–662 (1986).
- 32
Koenig, S. & Fauci, A. S. in AIDS: Etiology, Diagnosis, Treatment and Prevention, 2nd edn. (eds DeVita, V., Hellman. S. & Rosenberg, S.) (Lippincott, Philadelphia, in the press).
- 33
Laurence, J. et al. J. clin. Invest. 72, 2072–2081 (1983).
- 34
Shalaby, M. R. et al. Cell lmmun. 110, 140–148 (1987).
- 35
Stricker, R. B. et al. Nature 327, 710–713 (1987).
- 36
Ziegler, J. & Stites, D. P. Clin. Immunol. Immunopathol. 41, 305–313 (1986).
- 37
Donahue, R. E. et al. Nature 326, 200–203 (1987).
- 38
Weinhold, K. J. et al. Lancet i, 902–904 (1988).
- 39
Somasundaran, M. & Robinson, H. L. J. Virol. 61, 3114–3119 (1987).
- 40
Hoxie, J. et al. Science 234, 1123–1127 (1986).
- 41
Rasheed, S et al. Virology 154, 395–400 (1986).
- 42
Gupta, S. & Vayuvegula, B. J. clin. lmmun. 7, 486 (1987).
- 43
Lynn, W. S. et al. Virology 163, 43–51 (1988).
- 44
Keshet, E. & Temin, H. M. J. Virol. 31, 376–388 (1979).
- 45
Rutherford, G. W. & Werdegar, D. in AIDS: Pathogenesis and Treatment (ed. Levy, J. A.) (Dekker, New York, in the press).
- 46
Lang, W. et al. Abstr. Int. on Conf. AIDS, Stockholm abstr.) (1988).
- 47
Walker, B. et al. Nature 328, 345–348 (1987).
- 48
Plata, F. et al. Nature 328, 348–351 (1987).
- 49
Walker, C. M. et al. Science 234, 1563–1566 (1986).
- 50
Kannagi, M. et al. J. lmmun. 140, 2237–2242 (1988).
- 51
Lange, J. M. A. et al. Br. med. J. 293, 1459–1462 (1986).
- 52
Mosca, J. D. et al. Proc. natn. Acad. Sci. U.S.A. 84, 7408–7412 (1987).
- 53
Rojko, J. L. et al. Nature 298, 385–388 (1982).
- 54
Folks, T. M. et al. Science 231, 600–602 (1986).
- 55
Luciw, P. A. et al. Proc. natn. Acad. Sci. U.S.A. 84, 1434–1438 (1987).
- 56
Guy, B. et al. Nature 330, 266–269 (1987).
- 57
Farzadegan, H. et al. Ann. int. Med. 108, 785–790 (1988).
- 58
Levy, J. A. J. Am. med. Ass. 259, 3037–3038 (1988).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Levy, J. Mysteries of HIV: challenges for therapy and prevention. Nature 333, 519–522 (1988). https://doi.org/10.1038/333519a0
Issue Date:
Further reading
-
Nonlinear incidence Human immunodeficiency virus infection model with optimal control
International Journal of Modern Physics B (2020)
-
Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV)
Veterinary Microbiology (2015)
-
Safety and Efficacy of Allergen Immunotherapy in Patients with HIV and Allergic Rhinitis: Facts and Fiction
Current Treatment Options in Allergy (2015)
-
Persistence of IgE-Associated Allergy and Allergen-Specific IgE despite CD4+ T Cell Loss in AIDS
PLoS ONE (2014)
-
Modelling the Course of an HIV Infection: Insights from Ecology and Evolution
Viruses (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
